PCOS: a raising problem; due to recent trends

Anitha Thamarai Selvi Arumuga Nainar, Malarvizhi Loganathan


Background: Polycystic ovaries with its symptom complexes (PCOS) constitute about 30% of the cases seen every day in patients coming for scan in our hospital. Since PCOS is associated with various long-term complications it is important to analyze is its incidence and its cause for the increase.

Methods: The study included 600 women who came for USG for various complaints who had USG features of PCO. Their symptoms, marital and obstetric history was recorded their general appearance and BMI were also recorded and analysed. Their food pattern and physical activity was also elicited.

Results: PCO was a finding in around 24% of unwed teenage girls. PCO affected both obese (21.4%) and non-obese (56.2%) women. The complaints for which they come were mainly menstrual disturbances and primary (28.8%) infertility and secondary (22.6%) infertility.

Conclusions: Early identification of PCO is essential and its treatment will prevent various long-term complications of it in the future generation.


BMI Body Mass Index, PCOS Polycystic ovarian disease, PCO-polcystic ovaries, USG ultrasonogram

Full Text:



Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to Polycystic Ovary Syndrome (PCOS). Human Reproduction. 2004;19:41-7.

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006;91:4237-45.

Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10(8):2107-11

Willis DS, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab. 1998;83(11):3984-91.

Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003;88(12):5957-62.

Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC. Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod. 2004;19(9):2036-42.

McCartney CR, Blank SK, Prendergast KA, Chhabra S, Eagleson CA, Helm KD et al. Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. J Clin Endocrinol Metab. 2007;92:430-6.

Reinehr T, de Sousa G, Roth CL, Andler W. Androgens before and after weight loss in obese children. J Clin Endocrinol Metab. 2005;90(10):5588-95.

Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293-342.

Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008;14(4):367-78.